FDA Flags Eye Risk for Wegovy and Zepbound
Health officials warn that popular weight-loss shots carry a link to a rare eye condition.
Millions of Americans take new weight-loss drugs each week. Now, health regulators see a new safety concern for these blockbuster shots.
The Food and Drug Administration issued a fresh warning today. The agency found evidence linking GLP-1 drugs to a rare eye problem. This condition can cause sudden vision loss. The warning covers popular brands like Wegovy and Zepbound.
Doctors prescribe these drugs for diabetes and weight control. The eye condition remains rare. Still, regulators want patients to watch for changes in their sight.
Patients should speak with their doctors before changing their medicine. Knowing the risks helps people protect their health while pursuing their goals.
Source: CNBC
More from Biotech
